Nerve-Sparing Gynecologic Surgery Enabled by A Near-Infrared Nerve-Specific Fluorophore Using Existing Clinical Fluorescence Imaging Systems.

Patients undergoing gynecological procedures suffer from lasting side effects due to intraoperative nerve damage. Small, delicate nerves with complex and nonuniform branching patterns in the female pelvic neuroanatomy make nerve-sparing efforts during standard gynecological procedures such as hysterectomy, cystectomy, and colorectal cancer resection difficult, and thus many patients are left with incontinence and sexual dysfunction. Herein, a near-infrared (NIR) fluorescent nerve-specific contrast agent, LGW08-35, that is spectrally compatible with clinical fluorescence guided surgery (FGS) systems is formulated and characterized for rapid implementation for nerve-sparing gynecologic surgeries. The toxicology, pharmacokinetics (PK), and pharmacodynamics (PD) of micelle formulated LGW08-35 are examined, enabling the determination of the optimal imaging doses and time points, blood and tissue uptake parameters, and maximum tolerated dose (MTD). Application of the formulated fluorophore to imaging of female rat and swine pelvic neuroanatomy validates the continued clinical translation and use for real-time identification of important nerves such as the femoral, sciatic, lumbar, iliac, and hypogastric nerves. Further development of LGW08-35 for clinical use will unlock a valuable tool for surgeons in direct visualization of important nerves and contribute to the ongoing characterization of the female pelvic neuroanatomy to eliminate the debilitating side effects of nerve damage during gynecological procedures.

[1]  H. G. van der Poel,et al.  Quantifying the Impact of Signal-to-background Ratios on Surgical Discrimination of Fluorescent Lesions , 2022, Molecular Imaging and Biology.

[2]  A. Vahrmeijer,et al.  Fundamentals and developments in fluorescence-guided cancer surgery , 2021, Nature Reviews Clinical Oncology.

[3]  Connor W. Barth,et al.  Clinically Translatable Formulation Strategies for Systemic Administration of Nerve‐Specific Probes , 2021, Advanced therapeutics.

[4]  I. Alkatout,et al.  Review: Pelvic nerves – from anatomy and physiology to clinical applications , 2021, Translational neuroscience.

[5]  K. Kenton,et al.  Trends in Operative Time and Outcomes in Minimally Invasive Hysterectomy from 2008 to 2018. , 2020, American journal of obstetrics and gynecology.

[6]  Connor W. Barth,et al.  Near-infrared nerve-binding fluorophores for buried nerve tissue imaging , 2020, Science Translational Medicine.

[7]  M. Kaneuchi,et al.  Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer , 2020, Journal of gynecologic oncology.

[8]  Vidhi M. Shah,et al.  Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[9]  Sunil Singhal,et al.  Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer. , 2018, Journal of medicinal chemistry.

[10]  T. Usta,et al.  Laparoscopic evaluation of female pelvic neuroanatomy and autonomic plexuses in terms of gynecologic perspective , 2018, Journal of Endometriosis and Pelvic Pain Disorders.

[11]  Alexander L. Vahrmeijer,et al.  Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent , 2018, Annals of Surgical Oncology.

[12]  Travis L. Rice-Stitt,et al.  Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system , 2018, Breast Cancer Research and Treatment.

[13]  C. Morash,et al.  The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta‐Analysis , 2017, The Journal of urology.

[14]  Keith Paulsen,et al.  Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use , 2017, Molecular Imaging and Biology.

[15]  A. Harootunian,et al.  Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study , 2017, Annals of Surgical Oncology.

[16]  Vidhi M. Shah,et al.  Characterization of pegylated and non‐pegylated liposomal formulation for the delivery of hypoxia activated vinblastine‐N‐oxide for the treatment of solid tumors , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Connor W. Barth,et al.  Direct Administration of Nerve-Specific Contrast to Improve Nerve Sparing Radical Prostatectomy , 2017, Theranostics.

[18]  B. Heniford,et al.  Indocyanine Green , 2016, Surgical innovation.

[19]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[20]  F. Ghezzi,et al.  Nerve-sparing approach reduces sexual dysfunction in patients undergoing laparoscopic radical hysterectomy. , 2014, The journal of sexual medicine.

[21]  Hak Soo Choi,et al.  Prototype Nerve-Specific Near-Infrared Fluorophores , 2014, Theranostics.

[22]  A. Vahrmeijer,et al.  Image-guided cancer surgery using near-infrared fluorescence , 2013, Nature Reviews Clinical Oncology.

[23]  J. Silverman,et al.  Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine , 2012, Cancer Chemotherapy and Pharmacology.

[24]  John V. Frangioni,et al.  Nerve-Highlighting Fluorescent Contrast Agents for Image-Guided Surgery , 2011, Molecular imaging.

[25]  Knut Rurack,et al.  Fluorescence quantum yields of a series of red and near-infrared dyes emitting at 600-1000 nm. , 2011, Analytical chemistry.

[26]  Eva M. Sevick-Muraca,et al.  Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.

[27]  F. Ghezzi,et al.  Sexual function after radical hysterectomy for early-stage cervical cancer: is there a difference between laparoscopy and laparotomy? , 2009, The journal of sexual medicine.

[28]  F. Attarchi Exploratory IND Studies: A Review of Food and Drug Administration Guidance and Similar Provision in Europe , 2007 .

[29]  T. Kessler,et al.  Clinical indications and outcomes with nerve-sparing cystectomy in patients with bladder cancer. , 2005, The Urologic clinics of North America.

[30]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[31]  M. Groenvold,et al.  Early‐stage cervical carcinoma, radical hysterectomy, and sexual function , 2004, Cancer.